Bionumerik pharmaceuticals acquired
WebJan 21, 2010 · BioNumerik Pharmaceuticals, Inc., based in San Antonio, Texas, is focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care ... WebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve Carchedi to BioNumerik's Board of Directors.. Mr. Carchedi brings extensive pharmaceutical industry and oncology product commercialization experience to the …
Bionumerik pharmaceuticals acquired
Did you know?
WebCompany Description: BioNumerik Pharmaceuticals does biopharmaceutical drug development by the numbers. Using a multi-discipline process of identifying potential … WebBioNumerik Pharmaceuticals, Inc. Street Address 1 Street Address 2; 8122 DATAPOINT DRIVE: SUITE 1250: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SAN ANTONIO: TEXAS: 78229: 210-614-1701: 3. Related Persons. Last Name First Name Middle Name; Hausheer: Frederick: H. Street Address 1 Street Address 2; 8122 …
WebThe estimated total pay for a BioNumerik Pharmaceuticals is $55,502 per year in the United States area, with an average salary of $51,532 per year. These numbers represent the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated additional pay is ... Web51 to 200 Employees. Type: Company - Private. Industry: Biotech & Pharmaceuticals. Revenue: $5 to $25 million (USD) Competitors: Unknown. BioNumerik …
WebMar 18, 2008 · SAN ANTONIO and TOKYO, March 18 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") and ASKA Pharmaceutical Co., Ltd. ("ASKA") … WebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve …
WebNov 18, 2024 · 31% of BioNumerik Pharmaceuticals employees are Asian. 18% of BioNumerik Pharmaceuticals employees are Hispanic or Latino. The average …
WebFeb 7, 2008 · SAN ANTONIO, Feb. 7 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. today announced treatment of the first patient in a global Phase III clinical trial of BioNumerik's anticancer drug candidate known as Karenitecin(R) in advanced ovarian cancer patients. BioNumerik is developing Karenitecin (also known as BNP1350) as an … rctf 2021 xss_itWebJun 18, 2024 · BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer. Where We Are. 8122 Datapoint Dr San Antonio TX 78229 Workplace Type. On-site Workplace. Employees work from physical offices. Jobs At BioNumerik Pharmaceuticals. 0 Jobs All Jobs Content Data + Analytics ... rctf 2019WebBioNumerik Pharmaceuticals focuses on the discovery, development, and commercialization of novel drugs for the treatment of cancer and cancer-supportive care. It provides drugs by merging medicine, quantum and statistical mechanics, pharmaceutical development, and supercomputing. The company was founded in 1992 and is based in … how to speak with a japanese accentWebMar 18, 2008 · SAN ANTONIO and TOKYO, March 18 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") and ASKA Pharmaceutical Co., Ltd. ("ASKA") … how to speak with a russian accentWebMar 2, 2001 · The following is an excerpt from a S-1 SEC Filing, filed by BIONUMERIK PHARMACEUTICALS INC on 3/2/2001. Next Section: Previous Section ... was received by the receiving party from a third party who did not acquire it, directly or indirectly, from the disclosing party under any obligation of confidentiality and which the third party is free to ... rctf babyreWebOperating Agreement • August 24th, 2004 • Bionumerik Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware how to speak with a kentucky accentWebBioNumerik Pharmaceuticals. In January 2024, the Company entered into an Assignment Agreement (the “Assignment Agreement”) with BioNumerik Pharmaceuticals, Inc. (“BioNumerik”), pursuant to which the Company acquired rights to domestic and international patents, trademarks and related technology and data relating to LP-300 … how to speak with a lawyer